The city of Dallas, Texas, currently has 15 active clinical trials seeking participants for Healthy research studies.
The Longitudinal Study of Stimulant Use Disorder
Recruiting
This research is a 5-year observational, longitudinal registry study with no treatment or medication provided as part of participation. Individuals with current or lifetime stimulant use disorder, in addition to healthy control individuals, may be eligible to participate in this study. A variety of assessments and tasks including Magnetic Resonance Imaging (MRI), Electroencephalography (EEG), blood draws, urine drug screens, and both self-report and clinician-rated assessments will be used to as... Read More
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
12/11/2023
Locations: UT Southwestern Medical Center, Dallas, Texas
Conditions: Stimulant Use, Stimulant-Related Disorder, Healthy
A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants
Recruiting
Learn about the safety and tolerability of CK-3828136 after a single dose and multiple doses in healthy subjects. Find out how much CK-3828136 is in the blood after a single dose and multiple doses. Determine the effect different doses of CK-3828136 on the pumping function of the heart.
Gender:
All
Ages:
Between 18 years and 45 years
Trial Updated:
05/24/2023
Locations: Labcorp Clinical Research Unit Inc., Dallas, Texas
Conditions: Healthy Participants
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
Recruiting
The goal of this exploratory study is understand the mechanisms of response to immunotherapy in Non-Small Cell Lung Cancer patients. The investigators are going to search for correlation between specific biological features and response to immunotherapy, and to use those associations for developing an algorithm enabling to identify patients that could benefit from the immune check inhibitor based anti cancer treatment. Patients will provide biological samples before and during their treatment,... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/09/2023
Locations: Baylor Scott and White Research Institute, Dallas, Texas
Conditions: Non Small Cell Lung Cancer, Healthy